These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 9054280)

  • 1. Transdermal nicotine for mildly to moderately active ulcerative colitis. A randomized, double-blind, placebo-controlled trial.
    Sandborn WJ; Tremaine WJ; Offord KP; Lawson GM; Petersen BT; Batts KP; Croghan IT; Dale LC; Schroeder DR; Hurt RD
    Ann Intern Med; 1997 Mar; 126(5):364-71. PubMed ID: 9054280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotine tartrate liquid enemas for mildly to moderately active left-sided ulcerative colitis unresponsive to first-line therapy: a pilot study.
    Sandborn WJ; Tremaine WJ; Leighton JA; Lawson GM; Zins BJ; Compton RF; Mays DC; Lipsky JJ; Batts KP; Offord KP; Hurt RD; Green J
    Aliment Pharmacol Ther; 1997 Aug; 11(4):663-71. PubMed ID: 9305473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transdermal nicotine for active ulcerative colitis.
    Pullan RD; Rhodes J; Ganesh S; Mani V; Morris JS; Williams GT; Newcombe RG; Russell MA; Feyerabend C; Thomas GA
    N Engl J Med; 1994 Mar; 330(12):811-5. PubMed ID: 8114833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal nicotine as maintenance therapy for ulcerative colitis.
    Thomas GA; Rhodes J; Mani V; Williams GT; Newcombe RG; Russell MA; Feyerabend C
    N Engl J Med; 1995 Apr; 332(15):988-92. PubMed ID: 7885427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal nicotine compared with oral prednisolone therapy for active ulcerative colitis.
    Thomas GA; Rhodes J; Ragunath K; Mani V; Williams GT; Newcombe RG; Russell MA; Feyerabend C
    Eur J Gastroenterol Hepatol; 1996 Aug; 8(8):769-76. PubMed ID: 8864674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal nicotine for induction of remission in ulcerative colitis.
    McGrath J; McDonald JW; Macdonald JK
    Cochrane Database Syst Rev; 2004 Oct; (4):CD004722. PubMed ID: 15495126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of nicotine carbomer enemas: a new treatment modality for ulcerative colitis.
    Green JT; Thomas GA; Rhodes J; Evans BK; Russell MA; Feyerabend C; Fuller GS; Newcombe RG; Sandborn WJ
    Clin Pharmacol Ther; 1997 Mar; 61(3):340-8. PubMed ID: 9084459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial of nicotine enemas for active ulcerative colitis.
    Ingram JR; Thomas GA; Rhodes J; Green JT; Hawkes ND; Swift JL; Srivastava ED; Evans BK; Williams GT; Newcombe RG; Courtney E; Pillai S
    Clin Gastroenterol Hepatol; 2005 Nov; 3(11):1107-14. PubMed ID: 16271342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose nicotine patch therapy. Percentage of replacement and smoking cessation.
    Dale LC; Hurt RD; Offord KP; Lawson GM; Croghan IT; Schroeder DR
    JAMA; 1995 Nov; 274(17):1353-8. PubMed ID: 7563559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal nicotine and haloperidol in Tourette's disorder: a double-blind placebo-controlled study.
    Silver AA; Shytle RD; Philipp MK; Wilkinson BJ; McConville B; Sanberg PR
    J Clin Psychiatry; 2001 Sep; 62(9):707-14. PubMed ID: 11681767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A placebo-controlled trial of cyclosporine enemas for mildly to moderately active left-sided ulcerative colitis.
    Sandborn WJ; Tremaine WJ; Schroeder KW; Batts KP; Lawson GM; Steiner BL; Harrison JM; Zinsmeister AR
    Gastroenterology; 1994 Jun; 106(6):1429-35. PubMed ID: 8194687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Feagan BG; Macdonald JK
    Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement.
    Hurt RD; Dale LC; Fredrickson PA; Caldwell CC; Lee GA; Offord KP; Lauger GG; Marŭsić Z; Neese LW; Lundberg TG
    JAMA; 1994 Feb; 271(8):595-600. PubMed ID: 8301791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of a 16-hour transdermal nicotine patch in a medical practice setting, without intensive group counseling.
    Sachs DP; Säwe U; Leischow SJ
    Arch Intern Med; 1993 Aug; 153(16):1881-90. PubMed ID: 8110249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is transdermal nicotine associated with cardiovascular risk?
    Thomas GA; Davies SV; Rhodes J; Russell MA; Feyerabend C; Säwe U
    J R Coll Physicians Lond; 1995; 29(5):392-6. PubMed ID: 8847680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial.
    Hanauer SB; Sandborn WJ; Kornbluth A; Katz S; Safdi M; Woogen S; Regalli G; Yeh C; Smith-Hall N; Ajayi F
    Am J Gastroenterol; 2005 Nov; 100(11):2478-85. PubMed ID: 16279903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An oral formulation of nicotine for release and absorption in the colon: its development and pharmacokinetics.
    Green JT; Evans BK; Rhodes J; Thomas GA; Ranshaw C; Feyerabend C; Russell MA
    Br J Clin Pharmacol; 1999 Oct; 48(4):485-93. PubMed ID: 10583017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine replacement therapy for patients with coronary artery disease. Working Group for the Study of Transdermal Nicotine in Patients with Coronary artery disease.
    Arch Intern Med; 1994 May; 154(9):989-95. PubMed ID: 8179456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two studies of the clinical effectiveness of the nicotine patch with different counseling treatments.
    Fiore MC; Kenford SL; Jorenby DE; Wetter DW; Smith SS; Baker TB
    Chest; 1994 Feb; 105(2):524-33. PubMed ID: 8306757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varying nicotine patch dose and type of smoking cessation counseling.
    Jorenby DE; Smith SS; Fiore MC; Hurt RD; Offord KP; Croghan IT; Hays JT; Lewis SF; Baker TB
    JAMA; 1995 Nov; 274(17):1347-52. PubMed ID: 7563558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.